CME Group Inc Class A

CME: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|!rLOCK|#@?LOCK|Q<!!%Ss>

CME Benefits From Volatile Markets Through High Trading Volume and Revenue

Business Strategy and Outlook

CME Group enjoyed favorable market conditions in 2025, as volatility across multiple asset classes drove higher trading volume, resulting in strong revenue growth. CME has enjoyed accelerated revenue growth since 2022, as heightened interest-rate uncertainty has led to sustained growth in interest-rate futures volume. We expect this tailwind to persist in 2026 before diminishing in 2027, contributing to our expectation for a deceleration in growth next year.

Sponsor Center